Atria Investments’s iShares iBonds Dec 2031 Term Corporate ETF IBDW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.62M Buy
125,871
+13,698
+12% +$286K 0.03% 631
2026
Q1
$2.35M Buy
112,173
+6,580
+6% +$139K 0.03% 647
2025
Q4
$2.23M Buy
105,593
+95,286
+924% +$2.02M 0.03% 680
2025
Q3
$219K Buy
10,307
+375
+4% +$7.9K ﹤0.01% 1900
2025
Q2
$209K Buy
+9,932
New +$205K ﹤0.01% 1902

Other funds holding IBDW

Atria Investments's IBDW Position: Q2 2026 in Review

Atria Investments increased its iShares iBonds Dec 2031 Term Corporate ETF (IBDW) stake by 12% in Q2 2026, buying an estimated $286K and bringing the position to 125,871 shares worth $2.62M. The position accounts for 0.03% of the portfolio, ranked #631.

Atria Investments first reported a position in IBDW in Q2 2025 and has held it in 5 quarters since. 291 funds tracked by Wall St. Rank hold IBDW as of Q2 2026.

  • Atria Investments held 125,871 shares of iShares iBonds Dec 2031 Term Corporate ETF worth $2.62M as of Q2 2026.
  • Atria Investments bought 13,698 iShares iBonds Dec 2031 Term Corporate ETF shares in Q2 2026, an estimated $286K.
  • iShares iBonds Dec 2031 Term Corporate ETF made up 0.03% of Atria Investments's portfolio in Q2 2026, its #631 holding.
  • Atria Investments first reported a position in iShares iBonds Dec 2031 Term Corporate ETF in Q2 2025 and has held it in 5 quarters since.
  • 291 funds tracked by Wall St. Rank held iShares iBonds Dec 2031 Term Corporate ETF as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.